Senators, nonprofits respond to Trump’s avowed support for IVF

The Cancer Letter | |

<p>Last week, President Donald Trump announced a deal with pharmaceutical company Merck KGaA and its U.S. subsidiary, EMD Serono, to sharply reduce the cost of some fertility drugs used for in-vitro fertilization, in exchange for a three-year reprieve on some of the tariffs levied on pharmaceutical imports (The Cancer Letter, Oct. 24, 2025). This content [&#8230;]</p> <p>The post <a href="https://cancerletter.com/cancer-policy/20251031_5c/"…

Topics: oncology